|
[1] Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组．药物性肝损伤诊治指南[J]．临床肝胆病杂志，2015,31(11):1752-1769.
|
|
[2] WANG SW,XIE W. Research progress on high mobility group protein box 1 in drug induced liver injury[J/CD]. Chin J Liver Dis(Electronic Edition),2018,10(2):1-5.(in Chinese)王世伟，谢雯．高迁移率族蛋白-1在药物性肝损伤中的研究进展[J/CD]．中国肝脏病杂志(电子版)，2018,10(2):1-5.
|
|
[3] MA YB,LI YL,ZHANG J. Influence of ursodeoxycholic acid combined with S-adenosine methionine on liver function,Nrf2 antioxidant and inflammatory response in patients with drug-induced liver injury[J]. J Clin Exp Med,2018,17(24):2606-2610.(in Chinese)马雅斌，李语玲，张津．熊去氧胆酸联合S-腺苷蛋氨酸对药物性肝损伤患者肝功能、Nrf2抗氧化、炎症反应的影响[J]．临床和实验医学杂志，2018,17(24):2606-2610.
|
|
[4] HU PF,WANG PQ,CHEN H,et al. Beneficial effect of corticosteroids for patients with severe drug-induced liver injury[J]. J Dig Dis,2016,17(9):618-627.
|
|
[5] FONTANA RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives[J]. Gastroenterology,2014,146(4):914-928.
|
|
[6] KLEINER DE,CHALASANI NP,LEE WM,et al. Hepatic histological findings in suspected drug-induced liver injury:Systematic evaluation and clinical associations[J]. Hepatology,2014,59(2):661-670.
|
|
[7] ZHANG YG,ZHAO SX,LI WC,et al. Treatment response of glucocorticoid in severe drug-induced liver injury[J]. Liver,2017,22(3):214-218.
|
|
[8] DUPIRE G,DROITCOURT C,HUGHES C. Antistreptococcal interventions for guttate and chronic plaque psoriasis[J]. Cochrane Database Syst Rev,2019,3:CD011571.
|
|
[9] SARKAR MK,KAPLAN N,TSOI LC,et al. Endogenous glucocorticoid deficiency in psoriasis promotes inflammation and abnormal differentiation[J]. J Invest Dermatol,2017,137(7):1474-1483.
|
|
[10] NICKOLOFF BJ,NESTLE FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities[J]. J Clin Invest,2004,113(12):1664-1675.
|
|
[11] Specialized Committee on Autoimmunol Diseases,Chinese Medical Doctor Association Dermatology Branch. Expert consensus on the treatment of immune-related dermatosis with glucocorticoid(2018)[J]. Chin J Clin Immunol Allergy,2018,12(1):1-7.(in Chinese)中国医师协会皮肤科医师分会自身免疫性疾病亚专业委员会．糖皮质激素治疗免疫相关性皮肤病专家共识(2018年)[J]．中华临床免疫和变态反应杂志，2018,12(1):1-7.
|
|
[12] Ministry of Health. Guidelines for clinical application of glucocorticoids(excerpt)[J]. ADRJ,2011,13(1):40-44.(in Chinese)卫生部．糖皮质激素类药物临床应用指导原则(节选)[J]．药物不良反应杂志，2011,13(1):40-44.
|
|
[13] LEVINE D,GOTTLIEB A. Evaluation and management of psoriasis:An internist's guide[J]. Med Clin North Am,2009,93(6):1291-1303.
|
DownLoad: